Sour D Tarantula Joint from Ganja Gold Review bu OCWeedReview.Com
To me, Sour Diesel is “The” NYC strain, and Ganja Gold presents it here in a potent pre-roll. Coming from the East Coast myself, legend had it that all of the tri-state area was supplied from a single warehouse in Brooklyn. And it was always Sour D. While the likeliness of this is low, I do recall getting the same buds all through high school and again when I returned home for grad school. And it would explain the endless sativa high that conditioned me to love the cerebral effects of a strain like Sour D.
These Sour D tarantula joint pre-rolls are started with top shelf outdoor organic bud. Before being rolled in kief, they are given a base of CO2 oil to hold the powdery kief in place and ensuring a perfectly even burn, from start to end. The scent of these pre-rolls is noticeably a skunky diesel, the smell of weed as I know it. Loaded with the high-enhancing Myrcene and lung expanding Limonene terpenes, Sour D has a way of getting you that much higher than the next leading sativa strain.
An active strain, Sour Diesel is perfect for the hustle and bustle of the greater NYC area and separates itself from the characteristic mellow OG strains preferred here in SoCal. Patients will find these Sour D pre-rolls to be wonderful for depression and the psychosomatic side of stress and anxiety. High THC and low CBD numbers mean both lock and body effects are at a minimum, while heady effects are soaring.
First seen at OCWeedReview.Com
By John Schroyer
The 2014 election proved to be an encouraging one for the marijuana industry at large, setting the stage for hundreds of millions of additional dollars in cannabis commerce and scores of new business opportunities.
Pro-cannabis ballot measures prevailed inthree out of four key national battlegrounds, and even the one major disappointment – the narrow failure of Florida’s medical marijuana measure – provided reasons for optimism about the future.
Oregon and Alaska have joined Colorado and Washington in legalizing recreational marijuana, while Washington DC voters approved cannabis possession and use, which could pave the way for sales down the road. Guam also became the first United States territory to legalize medical marijuana, which could create more business opportunities for U.S. entrepreneurs.
This will all pave the way for additional marijuana ballot measures in 2016 and possibly legislative victories next year, putting the cannabis industry on good footing to close out 2014.
Here’s an overview of how key marijuana measures fared, the impact on the industry and reaction from business leaders and supporters.
Florida: Fight Will Continue
The Sunshine State was an early defeat on Tuesday night, with election results emerging at roughly the same time as the victory to the north, in Washington DC. The Florida campaign was an expensive one, with both sides expending millions of dollars on TV ads, both fighting to the bitter end.
That was a huge letdown to scores of cannabis entrepreneurs who were hoping to tap into what could easily become one of the country’s largest MMJ markets, with a population of 20 million and a sizable elderly demographic.
“It’s very, very disappointing,” said Mike Smullen, executive chairman of Altmed, a Florida cannabis company aiming to open a MMJ dispensary. Smullen and his team are still planning on moving forward with their business plan, in the hopes of getting one of five business permits the state will issue for high-CBD, low-THC medicine for epileptics.
Smullen said that Drug Free Florida, the campaign that opposed Amendment 2, ran “deceptive” ads based on “fear-mongering,” paid for in large part by more than $5 million from casino mogul Sheldon Adelson. People United for Medical Marijuana, the group behind Amendment 2, didn’t counter as well as they could have, Smullen said.
“This should not have happened. There was enough momentum,” Smullen said. “Perhaps we underestimated how effective those TV ads were in the last few weeks.”
But the fact that nearly 58% of voters supported MMJ is highly encouraging and would have ranked as a resounding victory in other states that only require a simple majority to pass such legislation.
John Morgan, the Orland trial attorney who spearheaded the campaign and funded it with millions of his own money, promised that the battle for MMJ isn’t over.
“This fight does not end tonight. This fight begins tonight. Tomorrow we go to Tallahassee,” Morgan said in a press release.
“The governor and the leadership of the House and Senate MUST listen to the people who gave them their jobs. They must act on this issue,” Morgan said. “If they don’t – we’ll be back on the ballot in 2016. And the will of the people WILL NOT be denied a second time.”
Oregon: Third in Line for History Books
Although Oregon voters had twice before rejected marijuana legalization, this time around 54% of voters gave the thumbs up toMeasure 91, which the head of the Drug Policy Alliance has called the “new gold standard” when it comes to recreational marijuana.
Results of the election came just a few hours before Alaska, technically making Oregon the third state in the nation to legalize rec sales.
“It’s a huge day in history,” gushed Claire Kaufmann, a cannabis industry consultant based in Portland. And it could prove a financial windfall for those positioned to cash in – annual sales could come in around $225 million to $275 million, according to Marijuana Business Media’s initial ballpark estimates.
Kaufmann and others see Oregon as a new potential national leader when it comes to the cannabis industry, in large part because the state can capitalize on the trials, errors and successes in both Colorado and Washington.
“What’s wonderful about being in Oregon is we had the opportunity to learn from Colorado and Washington,” Kaufmann said. “We’re going to do some amazing things, not only when it comes to research and development, but also when it comes to safety and implementation.”
The measure also took a different campaign approach from many past victories, in focusing on undercutting the black market, and utilizing law enforcement officials in promoting the initiative.
Alaska: An Unknown Frontier
Recreational marijuana sales face a fairly uncertain future in Alaska, which – like Washington State before it – doesn’t have an existing medical marijuana regulatory system. Dispensaries are not allowed under the state’s MMJ law, so Alaska will be approaching this from scratch.
The major questions now are tied to regulations. Will the state decide to establish a cap on the number of stores and cultivation sites allowed? What will the tax rate be? Will vertical integration be mandatory, an option or not allowed at all? The answers to all of these questions will ultimately determine the level of business opportunities and the size of the market.
The Alaska market is significantly smaller than Washington, Colorado or Oregon, with a population of just 735,000. Still, retail marijuana could generate between $45 million to $55 million in annual sales initially, according to Marijuana Business Media’s estimates.
Washington DC: A Beginning or an End?
Arguably the most tenuous of victories on Tuesday was Initiative 71 in the U.S. capital, which legalized adult use and possession of marijuana for recreational purposes, while leaving sales illegal. The measure passed by an enormous margin, with almost 65% support, but it might prove a symbolic victory if Congress decides to overturn the law.
Roll Call reported on Tuesday that U.S. Sen. Rand Paul, R-KY, who heads a Congressional panel that oversees DC laws, is inclined to respect the will of district voters. But Paul’s colleagues might not feel the same way, so the cannabis win could be short-lived.
But if 71 is allowed to stand, then the DC city council may wind up approving recreational sales in the near future. It’s a possibility that’s already been reported by more than one news outlet, including The Washington Post. If that happens, it could create a $130 million market, with estimated tax revenue of $20 million a year.
John Schroyer can be reached at Johns@mjbizmedia.com
Marijuana Industry Could Be Worth $35 Billion In 2020, If All States And Feds Legalize It
If all 50 states legalized marijuana and the federal government ended prohibition of the plant, the marijuana industry in the United States would be worth $35 billion just six years from now.
That’s according to a new report from GreenWave Advisors, a research and advisory firm that serves the emerging marijuana industry in the U.S., which found that if all 50 states and the federal government legalized cannabis, combined sales for both medical and retail marijuana could balloon to $35 billion a year by 2020.
If the federal government doesn’t end prohibition and the trajectory of state legalization continues on its current path, with more, but not all, states legalizing marijuana in some form, the industry in 2020 would still be worth $21 billion, GreenWave projects.
In its $21 billion 2020 model, GreenWave predicts 12 states plus the District of Columbia to have legalized recreational marijuana (besides Colorado and Washington, which legalized it in 2012). Those states are: Alaska, Arizona, California, Hawaii, Maine, Maryland, Massachusetts, Nevada, New Hampshire, Oregon, Rhode Island and Vermont, according to data GreenWave provided to The Huffington Post from the full report. By that same year, the model assumes, 37 states will have legalized medical marijuana. To date, 23 states and the District of Columbia have legalized marijuana for medical use.
“Our road map for the progression of states to legalize is very detailed –- our assumptions are largely predicated on whether a particular state has legislation in progress,” Matt Karnes, founder and managing partner of GreenWave as well as author of the report, told HuffPost. “We assume that once legalization occurs, it will take a little over a year to implement a program and have product available for sale. So for example, for Florida, we expect the ballot measure to pass [this year] yet our sales forecast starts in year 2016. We think the time frame will lessen as new states to legalize will benefit from best practices.”
As Karnes noted, some of these states are already considering legalization this November — voters in Oregon, Alaska and D.C. are considering measures to legalize recreational marijuana, while Florida voters will weigh in on medical marijuana legalization.
GreenWave isn’t the first group to suggest the federal government may end its decadeslong prohibition of marijuana. One congressman has even predicted that before the end of the decade, the federal government will legalize weed. And as outlandish as it may sound, it’s already possible to observe significant shifts in federal policy toward pot.
The federal government allowed Colorado’s and Washington’s historic marijuana laws to take effect last year. President Barack Obama signed the 2014 farm bill, which legalized industrial hemp production for research purposes in the states that permit it, and the first hemp crops in U.S. soil in decades are already growing. And in May, the U.S. House passed measures attempting to limit Drug Enforcement Administration crackdowns on medical marijuana shops when they’re legal in a state.
The GreenWave report also projects a substantial shift in the marijuana marketplace — the merging of the medical and recreational markets in states that have both.
“In the state of Colorado, we are beginning to see the sales impact — i.e., cannibalization of medical marijuana sales by the adult-use market — when the two markets co-exist,” Karnes said. “We expect a similar dynamic to unfold in those states that will implement a dual marijuana market.”
Beginning in July, recreational marijuana sales in Colorado began to outpace medical for the first time, according to state Department of Revenue data.
Karnes writes in the executive summary that just what the marijuana industry will look like in 2020 will largely depend on how the industry is regulated and how it is taxed by that time.
“Since ‘chronic pain’ is the most common ailment among medical marijuana users, it is likely that recreational users can already purchase marijuana without great difficulty in states where medicinal use is legal,” the report reads. “Accordingly, it can be argued that a merged market already exists in medical marijuana states. Less currently popular, but arguably providing more economic stimulus, would be a regulatory regime providing for only adult recreational use.”
Joe Rogan, Snoop Dogg, and Virgin Group founder Richard Branson will appear in the crowd-fundeddocumentary called the The Culture High, opening October 17 in limited theaters. In it, they explain their opposition to the war on drugs and their support for marijuana legalization. Branson shared this trailer for the movie in a post on Virgin’s website on Wednesday:
One of the big questions raised by the trailer is why politicians are taking so long to embrace legalization andmedical marijuana when both issues have so much support. (About 58 percent of Americans back full legalization, according to Gallup.)
When I posed the question to experts on social movements, they said marijuana just doesn’t have the priority among the electorate or kind of fundraising potential that politicians need to take on an issue.
Politicians generally need a concerted movement “that will give [them] time and money and networks [they] can’t get otherwise,” said Daniel Schlozman, a political scientist at Johns Hopkins University, in a previous interview. “Without that kind of preference intensity, if you’re [Senator] Bernie Sanders, you’re going to want to talk about social democracy, and if you’re [Senator] Elizabeth Warren, you’re going to want to talk about the banks. There’s no particular reason for you to dilute your core efforts to move the party.”
But as the political pressure builds, some politicians are beginning to move toward public opinion on the issue. Likely 2016 presidential candidate Hillary Clinton previously said “there’s a lot of evidence to argue for the medical marijuana thing” and that she’s open to letting the states act as “the laboratories of democracy” for full legalization efforts.
If Clinton’s comments are any indication, prominent Democrats are at least preparing for marijuana to turn into a national political issue in the future.
With 1 million signatures = A law on cannabis in Europe
Weed like to Talk is the first law proposal addressed to the European Commission to legalise the consumption of cannabis in Europe. This is an unprecendented chance to legalise cannabis in Europe. We need one million signatures to be heard, the European Parliament may then vote this law proposal.
Support here >> http://goo.gl/ZaKEvD
Thursday November 20th
European Commission, Brussels Belgium